Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikiko Shimizu

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
British Journal of Clinical Pharmacology|February 21, 2006
Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype statusTsukasa Uno, Mikiko Shimizu, Norio Yasui-Furukori, et al.
European Journal of Clinical Pharmacology|June 20, 2006
Effects of clarithromycin and verapamil on rabeprazole pharmacokinetics between CYP2C19 genotypesMikiko Shimizu, Tsukasa Uno, Norio Yasui-Furukori, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 10, 2005
Determination of rabeprazole and its active metabolite, rabeprazole thioether in human plasma by column-switching high-performance liquid chromatography and its application to pharmacokinetic studyTsukasa Uno, Norio Yasui-Furukori, Mikiko Shimizu, et al.
Plos One|October 17, 2015
Meta-Analysis: Effects of Probiotic Supplementation on Lipid Profiles in Normal to Mildly Hypercholesterolemic IndividualsMikiko Shimizu, Masayuki Hashiguchi, Tsuyoshi Shiga, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 28, 2018
Risk factors for rhabdomyolysis with HMG-CoA reductase inhibitors identified using a postmarketing surveillance database in Japan
Masayuki Hashiguchi, Jun Hakamata, Mikiko Shimizu, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 27, 2005
Isovolumic but not ejection phase Doppler tissue indices detect left ventricular dysfunction caused by coronary stenosisMikiko Shimizu, Masaki Nii, Igor E Konstantinov, et al.
Plos One|December 8, 2015
Factors Affecting the Timing of Signal Detection of Adverse Drug ReactionsMasayuki Hashiguchi, Shungo Imai, Keiko Uehara, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 18, 2015
Quantitation of pilsicainide in microscale samples of human biological fluids using liquid chromatography-tandem mass spectrometryMikiko Shimizu, Masayuki Hashiguchi, Tsuyoshi Shiga, et al.
European Journal of Clinical Pharmacology|August 18, 2006
Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curveTakenori Niioka, Tsukasa Uno, Norio Yasui-Furukori, et al.
Journal of Pharmacy Practice|November 30, 2022
Meta-Analysis Comparing Bivalirudin Versus. Unfractionated Heparin in Adult Patients With Extracorporeal Membrane OxygenationKazuhiko Kido, Galen M Kabulski, Thomas W Szymanski, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
British Journal of Clinical Pharmacology|February 21, 2006
Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype statusTsukasa Uno, Mikiko Shimizu, Norio Yasui-Furukori, et al.
European Journal of Clinical Pharmacology|June 20, 2006
Effects of clarithromycin and verapamil on rabeprazole pharmacokinetics between CYP2C19 genotypesMikiko Shimizu, Tsukasa Uno, Norio Yasui-Furukori, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 10, 2005
Determination of rabeprazole and its active metabolite, rabeprazole thioether in human plasma by column-switching high-performance liquid chromatography and its application to pharmacokinetic studyTsukasa Uno, Norio Yasui-Furukori, Mikiko Shimizu, et al.
Plos One|October 17, 2015
Meta-Analysis: Effects of Probiotic Supplementation on Lipid Profiles in Normal to Mildly Hypercholesterolemic IndividualsMikiko Shimizu, Masayuki Hashiguchi, Tsuyoshi Shiga, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 28, 2018
Risk factors for rhabdomyolysis with HMG-CoA reductase inhibitors identified using a postmarketing surveillance database in Japan
Masayuki Hashiguchi, Jun Hakamata, Mikiko Shimizu, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 27, 2005
Isovolumic but not ejection phase Doppler tissue indices detect left ventricular dysfunction caused by coronary stenosisMikiko Shimizu, Masaki Nii, Igor E Konstantinov, et al.
Plos One|December 8, 2015
Factors Affecting the Timing of Signal Detection of Adverse Drug ReactionsMasayuki Hashiguchi, Shungo Imai, Keiko Uehara, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 18, 2015
Quantitation of pilsicainide in microscale samples of human biological fluids using liquid chromatography-tandem mass spectrometryMikiko Shimizu, Masayuki Hashiguchi, Tsuyoshi Shiga, et al.
European Journal of Clinical Pharmacology|August 18, 2006
Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curveTakenori Niioka, Tsukasa Uno, Norio Yasui-Furukori, et al.
Journal of Pharmacy Practice|November 30, 2022
Meta-Analysis Comparing Bivalirudin Versus. Unfractionated Heparin in Adult Patients With Extracorporeal Membrane OxygenationKazuhiko Kido, Galen M Kabulski, Thomas W Szymanski, et al.
Pageof 7